These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. NT-proBNP predicts maintenance of sinus rhythm after electrical cardioversion. Andersson J; Rosenqvist M; Tornvall P; Boman K Thromb Res; 2015 Feb; 135(2):289-91. PubMed ID: 25481046 [TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance. Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436 [TBL] [Abstract][Full Text] [Related]
7. Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation. Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Goudis CA; Maliaraki NE; Saloustros IG; Milathianaki ME; Chlouverakis GI; Vardas PE Am J Cardiol; 2010 Jan; 105(1):90-4. PubMed ID: 20102897 [TBL] [Abstract][Full Text] [Related]
8. Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. Shin DI; Jaekel K; Schley P; Sause A; Müller M; Fueth R; Scheffold T; Guelker H; Horlitz M Z Kardiol; 2005 Dec; 94(12):795-800. PubMed ID: 16382379 [TBL] [Abstract][Full Text] [Related]
9. Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function. Barassi A; Pezzilli R; Morselli-Labate AM; Lombardi F; Belletti S; Dogliotti G; Corsi MM; Merlini G; Melzi d'Eril GV Can J Cardiol; 2012; 28(5):537-41. PubMed ID: 22552174 [TBL] [Abstract][Full Text] [Related]
10. Bone Morphogenetic Protein 10-A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation. Hennings E; Blum S; Aeschbacher S; Coslovsky M; Knecht S; Eken C; Lischer M; Paladini RE; Krisai P; Reichlin T; Rodondi N; Beer JH; Ammann P; Conte G; De Perna ML; Kobza R; Blum MR; Bossard M; Kastner P; Ziegler A; Müller C; Bonati LH; Pfister O; Zuern CS; Conen D; Kühne M; Osswald S; J Am Heart Assoc; 2023 Mar; 12(6):e028255. PubMed ID: 36926939 [TBL] [Abstract][Full Text] [Related]
11. Whole Blood Gene Expression Differentiates between Atrial Fibrillation and Sinus Rhythm after Cardioversion. Raman K; Aeschbacher S; Bossard M; Hochgruber T; Zimmermann AJ; Kaufmann BA; Pumpol K; Rickenbacker P; Paré G; Conen D PLoS One; 2016; 11(6):e0157550. PubMed ID: 27332823 [TBL] [Abstract][Full Text] [Related]
12. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function. Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126 [TBL] [Abstract][Full Text] [Related]
13. Predictive value of plasma Nt-proBNP and body mass index for recurrence of atrial fibrillation after cardioversion. Freynhofer MK; Jarai R; Höchtl T; Bruno V; Vogel B; Aydinkoc K; Nürnberg M; Wojta J; Huber K Int J Cardiol; 2011 Jun; 149(2):257-259. PubMed ID: 21377224 [No Abstract] [Full Text] [Related]
14. Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation. Hwang HJ; Son JW; Nam BH; Joung B; Lee B; Kim JB; Lee MH; Jang Y; Chung N; Shim WH; Cho SY; Kim SS Clin Res Cardiol; 2009 Apr; 98(4):213-8. PubMed ID: 19229464 [TBL] [Abstract][Full Text] [Related]
15. Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study. Kumarathurai P; Mouridsen MR; Mattsson N; Larsen BS; Nielsen OW; Gerds TA; Sajadieh A Europace; 2017 Mar; 19(3):364-370. PubMed ID: 27194537 [TBL] [Abstract][Full Text] [Related]
16. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation. Buob A; Jung J; Siaplaouras S; Neuberger HR; Mewis C Pacing Clin Electrophysiol; 2006 Jun; 29(6):559-63. PubMed ID: 16784419 [TBL] [Abstract][Full Text] [Related]
17. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea. Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868 [TBL] [Abstract][Full Text] [Related]
18. Relationship between Brain Natriuretic Peptide and Recurrence of Atrial Fibrillation after Successful Electrical Cardioversion: an Updated Meta-Analysis. Xu X; Tang Y Braz J Cardiovasc Surg; 2017; 32(6):530-535. PubMed ID: 29267617 [TBL] [Abstract][Full Text] [Related]
19. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study. Xiao J; Persson AP; Engström G; Johnson LSB BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943 [TBL] [Abstract][Full Text] [Related]
20. [Influence of electrical cardioversion on troponine I and brain natriuretic peptide (NT-proBNP) levels in patients with persistent atrial fibrillation/flutter]. Puljević M; Nevajda B; Sicaja M; Puljević D; Milicić D Lijec Vjesn; 2008; 130(7-8):175-8. PubMed ID: 18979903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]